Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04687761
Title Clinical Trial to Assess the Safety and Tolerability of the Combination of Low-dose Cytarabine or Azacitidine Plus Venetoclax and Quizartinib in Newly Diagnosed AML Patients Aged Equal or More Than 60 Years Old
Recruitment Unknown status
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors PETHEMA Foundation
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP

Facility Status City State Zip Country Details
Hospital Universitario Príncipe de Asturias NOT_YET_RECRUITING Alcalá De Henares Spain Details
Hospital Clínic RECRUITING Barcelona Spain Details
Hospital San Pedro de Alcántara RECRUITING Cáceres Spain Details
Hospital Universitario de Jerez de La Frontera RECRUITING Jerez De La Frontera Spain Details
Hospital de León (Complejo Asistencial Universitario de León) RECRUITING León Spain Details
Hospital Universitari Arnau de Vilanova de Lleida RECRUITING Lleida Spain Details
Hospital Universitario Infanta Leonor NOT_YET_RECRUITING Madrid Spain Details
Hospital Universitario La Zarzuela RECRUITING Madrid Spain Details
Hospital Universitario Puerta de Hierro Majadahonda NOT_YET_RECRUITING Majadahonda Spain Details
Hospital de Sant Joan de Deu (Manresa) RECRUITING Manresa Spain Details
Hospital Clinico Universitario Virgen de La Arrixaca RECRUITING Murcia Spain Details
Hospital Universitari Son Espases RECRUITING Palma De Mallorca Spain Details
Hospital Universitario Marques de Valdecilla RECRUITING Santander Spain Details
Hospital Universitari Mutua de Terrassa RECRUITING Terrassa Spain Details
Hospital Universitario y Politécnico La Fe RECRUITING Valencia Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field